According to Lieyunwang, on September 5th, 2019,Leyue Health, a medical big data, and health insurance provider,announced the completion of a Series B financing of 115 million yuan, led by Cowin Capital and followed by CASI.
"After this round of financing, Leyue will further expand its advantage in the construction of medical data network and its data service capabilities in the health insurance field," said Fu Xinhua, founder of Leyue health.
Leyue Health is an insurance pay online platform found by Leyue Information Technology (Shanghai) co., LTD. This platform provides commercial insurance online rapid settlement of one-stop service development and operations for medical institutions and insurance institutions. Through its online service, the traditional settling for the longest 30 days can be shortened to real-time settlement. For solving the problems about claims difficulties, slow reimbursement, complicated formalities of commercial insurance, Leyue Health has become the forerunner in the commercial insurance industry.
Cowin Capital Group was established on June 26, 2000, as China's first professional private placement Equity investment company. Cowin Capital 's capital management scale was among the front rank, which invested more than 300 companies.
The company mainly invests in the pioneering enterprise on a long-term basis, always keeping steady development. Companies to invest as the starting point, Cowin Capital is committed to supporting the growth of small and medium enterprises.
CAS Investment Management's controlling shareholder is the Chinese Academy of Sciences Holdings Co., Ltd. Its predecessor is the Chinese National Economic Council-CAS Scientific and Technological Promotion & Economic Development Foundation. With a mission of “Providing capital support and value-added service to industry leaders, and promoting them to be outstanding companies with international competitiveness”, CASI is dedicated to being a Chinese leading PE fund manager.